Spatial- and Valence-Matched Neutralizing DNA Nanostructure Blocks Wild-Type SARS-CoV-2 and Omicron Variant Infection

ACS Nano. 2022 Sep 27;16(9):15310-15317. doi: 10.1021/acsnano.2c06803. Epub 2022 Sep 8.

Abstract

Natural ligand-receptor interactions that play pivotal roles in biological events are ideal models for design and assembly of artificial recognition molecules. Herein, aiming at the structural characteristics of the spike trimer and infection mechanism of SARS-CoV-2, we have designed a DNA framework-guided spatial-patterned neutralizing aptamer trimer for SARS-CoV-2 neutralization. The ∼5.8 nm tetrahedral DNA framework affords precise spatial organization and matched valence as four neutralizing aptamers (MATCH-4), which matches with nanometer precision the topmost surface of SARS-CoV-2 spike trimer, enhancing the interaction between MATCH-4 and spike trimer. Moreover, the DNA framework provides a dimensionally complementary nanoscale barrier to prevent the spike trimer-ACE2 interaction and the conformational transition, thereby inhibiting SARS-CoV-2-host cell fusion and infection. As a result, the spatial- and valence-matched MATCH-4 ensures improved binding affinity and neutralizing activity against SARS-CoV-2 and its varied mutant strains, particularly the current Omicron variant, that are evasive of the majority of existing neutralizing antibodies. In addition, because neutralizing aptamers specific to other targets can be evolved and assembled, the present design has the potential to inhibit other wide-range and emerging pathogens.

Keywords: Omicron; SARS-CoV-2 neutralization; neutralizing aptamer; spatial-patterned interaction; DNA nanotechnology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19*
  • DNA
  • Humans
  • Ligands
  • Membrane Glycoproteins
  • Nanostructures*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics
  • Viral Envelope Proteins / chemistry

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Ligands
  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • spike protein, SARS-CoV-2
  • DNA
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants